GLP-1 drugs like Ozempic and Wegovy are transforming public health and consumer habits. Here we explore their explosive ...

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...

When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

ORLANDO -- Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective ...

Because GLP-1 agonists seem to reduce patients’ desire for food, it isn’t surprising that they might also shrink or even ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...

GLP‑1–pathway agonists such as semaglutide and newer multi‑agonists have transformed care for obesity and diabetes, yet ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.